palmidrol has been researched along with Mental Disorders in 2 studies
palmidrol: a cannabinoid receptor-inactive eCB-related molecule used as prophylactic in helping to prevent respiratory viral infection
palmitoyl ethanolamide : An N-(long-chain-acyl)ethanolamine that is the ethanolamide of palmitic (hexadecanoic) acid.
Mental Disorders: Psychiatric illness or diseases manifested by breakdowns in the adaptational process expressed primarily as abnormalities of thought, feeling, and behavior producing either distress or impairment of function.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, MP | 1 |
| Behm, B | 1 |
| Mehta, Z | 1 |
| Fernandez, C | 1 |
| Fidaleo, M | 1 |
| Fanelli, F | 1 |
| Ceru, MP | 1 |
| Moreno, S | 1 |
2 reviews available for palmidrol and Mental Disorders
| Article | Year |
|---|---|
The Potential Benefits of Palmitoylethanolamide in Palliation: A Qualitative Systematic Review.
Topics: Amides; Animals; Ethanolamines; Humans; Mental Disorders; Neurodegenerative Diseases; Pain; Palmitic | 2019 |
Neuroprotective properties of peroxisome proliferator-activated receptor alpha (PPARĪ±) and its lipid ligands.
Topics: Amides; Animals; Endocannabinoids; Ethanolamines; Humans; Ligands; Mental Disorders; Neurodegenerati | 2014 |